Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,121 | 1,233 | 517 | -214 | -5 |
| Other Working Capital | 209 | 486 | 77 | -149 | 11 |
| Other Operating Activity | -1,702 | -2,212 | -1,015 | -24 | 0 |
| Operating Cash Flow | $-373 | $-493 | $-420 | $-387 | $6 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -116,150 | -116,150 | -116,150 | N/A |
| Other Investing Activity | -360 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-360 | $-116,150 | $-116,150 | $-116,150 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 510 | 200 | 200 | 200 | 192 |
| Debt Repayment | N/A | -209 | -209 | -200 | N/A |
| Common Stock Issued | N/A | 120,325 | 120,325 | 120,325 | 25 |
| Common Stock Repurchased | N/A | N/A | N/A | -9 | N/A |
| Other Financing Activity | 0 | -3,338 | -3,338 | -3,338 | -221 |
| Financing Cash Flow | $510 | $116,979 | $116,979 | $116,979 | $-5 |
| Beginning Cash Position | 341 | 5 | 5 | 5 | 5 |
| End Cash Position | 118 | 341 | 414 | 447 | 7 |
| Net Cash Flow | $-223 | $336 | $409 | $442 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -373 | -493 | -420 | -387 | 6 |
| Free Cash Flow | -373 | -493 | -420 | -387 | 6 |